Bisphosphonates for advanced prostate cancer

Author:

Yuen Kwok Keung1,Shelley Mike2,Sze Wai Man3,Wilt Timothy J.4,Mason Malcolm5

Affiliation:

1. Tuen Mun Hospital; Department of Clinical Oncology; Hong Kong China

2. Velindre NHS Trust; Cochrane Prostatic Diseases and Urological Cancers Unit, Research Dept; Velindre Road Whitchurch Cardiff Wales UK CF4 7XL

3. Pamela Youde Nethersole Eastern Hospital; Clinical Oncology; LG1 East Block 3 Lok Man Road Hong Kong China

4. VAMC; General Internal Medicine (111-0); One Veterans Drive Minneapolis Minnesota USA 55417

5. Velindre Hospital; Clinical Oncology; Whitchurch Cardiff UK CF4 7XL

Publisher

Wiley

Subject

Pharmacology (medical)

Reference51 articles.

1. Clodronate therapy of metastatic bone disease in patients with prostatic carcinoma;Adami;Recent Results in Cancer Research 116: 67-72,,1989

2. A double-blind, placebo-controlled, randomised trial of oral sodium clodronate for metastatic prostate cancer (MRC PRO5 Trial);Dearnaley;Journal of the National Cancer Institute, vol 95, No 17 Sep 3, 1300-11,,2003

3. Effect of oral clodronate on bone pain: A controlled study in patients with metastatic prostate cancer.;Elomma;International Journal of Urology and Nephrology,1992

4. Randomized, double-blind, controlled trial of mitoxantron/prednisone and clodronate versus mitoxantrone/prednisone and placebo in patiens with hormone-refractory prostate cancer and pain;Ernst;Journal of Clinical Oncology,2003

5. Evaluation of the effect of oral clodronate on skeletal metastases with type I collagen metabolites. A controlled trial of the Finnish Prostate Cancer Group;Kylmala;European Journal of Cancer,1993

Cited by 92 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Urologische Tumoren;PET/CT-Atlas;2024

2. Supportive therapy and complementary medicine in renal cell carcinoma;World Journal of Urology;2021-11-25

3. Spinal Stereotactic Body Radiotherapy (SBRT) Planning Techniques;Ionizing and Non-ionizing Radiation;2020-01-15

4. Bisphosphonates;Journal of Pain and Symptom Management;2019-05

5. The Treatment of Metastatic and Castration-Resistant Prostate Cancer Patients in Korea;The Korean Journal of Urological Oncology;2019-04-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3